Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Is NVAX stock a buy or a sell? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

2 Variant Available Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant will target the JN.1 variant — a predecessor of KP.2.

2 Variant Available Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant will target the JN.1 variant — a predecessor of ...

while Novavax’s Matrix-M adjuvant enhances and broadens the immune response. The vaccine is packaged as a ready-to-use liquid formulation and is stored at 2° to 8°C, enabling the use of existing ...

Novavax’s COVID-19 vaccine, and others. “We’re a pretty new company to the space of vaccine adjuvants, but we have demonstrated that we have a technology that is scalable,” explained Salinas.

Maryland-based Novavax said that adding its adjuvant, which aims to boost the body’s immune response, did enhance the vaccine’s effectiveness. Novavax has received funding from Operation Warp ...

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...